SNU Open Repository and Archive: Browsing S-Space

Browse

S-Space

Browsing by Author Kang, Yoon-Koo

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 20 of 20

Issue Date	Title / Author(s) / Citation	File
2001-04	Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study Kang, Won Ki; Park, Chaehwa; Yoon, Hyunah Lee; Kim, Won Seog; Yoon, Sung-Soo; Lee, Mark H.; Park, Keunchil; Kim, Kihyun; Jeong, Hyun Sik; Kim, Jeong-A; Nam, Seok-Jin; Yang, Jung-Hyun; Son, Young-Ik; Baek, Chung-Hwan; Han, Jungho; Ree, Howe J.; Lee, Eil Soo; Kim, Sun Hee; Kim, Dae-Won; Ahn, Yong Chan; Huh, Seung Jae; Choe, Yeon Hyeon; Lee, Je-Ho; Park, Mary H.; Kong, Gyoung-Sun; Park, Eun-Young; Kang, Yoon-Koo; Bang, Yung-Jue; Paik, Nam-Sun; Lee, Soon Nam; Kim, Seon-Hee; Kim, Sunyoung; Robbins, Paul D.; Tahara, Hideaki; Lotze, Michael T.; Park, Chan H. Human Gene Therapy, Vol.12 No.6, pp.671-684	DOI
2002-07	Docetaxel 75 mg/m2 is active and well tolerated in patients with metastatic or recurrent gastric cancer: A phase II trial Bang, Yung-Jue; Kang, Won Ki; Kang, Yoon-Koo; Kim, Hugh Chul; Jacques, Christian; Zuber, Emmanuel; Daglish, Byzance; Boudraa, Yvane; Kim, Won Seog; Heo, Dae Seog; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.32 No.7, pp.248-254	DOI
2002-09	Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial Bang, Yung-Jue; Kang, Won Ki; Kang, Yoon-Koo; Kim, Hugh Chul; Jacques, Christian; Zuber, Emmanuel; Daglish, Byzance; Boudraa, Yvane; Kim, Won Seog; Heo, Dae Seog; Kim, Noe Kyeong Jpn J Clin Oncol 2002;32:248-54	link
2007-07	Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea-Japan collaborative study group trial Kim, Yeul Hong; Yamaguchi, Kensei; Bang, Yung-Jue; Takiuchi, Hiroya; Kang, Won Ki; Sato, Atsushi; Kang, Yoon-Koo; Sakamoto, Junichi; Abe, Chigusa; Sakata, Yuh Japanese Journal of Clinical Oncology, Vol.37 No.7, pp.501-508	link
2009	Kinase Mutations and Efficacy of Imatinib in Korean Patients with Advanced Gastrointestinal Stromal Tumors Kim, Tae Won; Ryu, Min-Hee; Lee, Heungnam; Sym, Sun Jin; Lee, Jae-Lyun; Chang, Heung Moon; Park, Young Suk; Lee, Kyung Hee; Kang, Won Ki; Shin, Dong Bok; Bang, Yung-Jue; Lee, Jung Shin; Kang, Yoon-Koo Oncologist, Vol.14 No.5, pp.540-547	DOI
2009-04	A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor Ryu, Min-Hee; Kang, Won Ki; Bang, Yung-Jue; Lee, Kyung Hee; Shin, Dong Bok; Ryoo, Baek-Yeol; Roh, Jae Kyung; Kang, Jin-Hyoung; Lee, Hyoungnam; Kim, Tae Won; Chang, Heung Moon; Park, Joon Oh; Park, Young Suk; Kim, Tae-You; Kim, Min Kyoung; Lee, Woon Kee; Kang, Hye Jin; Kang, Yoon-Koo Oncology, Vol.76 No.5, pp.326-332	DOI
2010-11	Clinical Practice Guideline for Accurate Diagnosis and Effective Treatment of Gastrointestinal Stromal Tumor in Korea Kang, Yoon-Koo; Kim, Kyoung-Mee; Sohn, Taesung; Choi, Dongil; Ryu, Min-Hee; Yang, Han-Kwang; Kim, Woo Ho; Kang, Hye Jin JOURNAL OF KOREAN MEDICAL SCIENCE; Vol.25 11; 1543-1552	view file DOI
2011-12	Phase II study of sunitinib as second-line treatment for advanced gastric cancer Bang, Yung-Jue; Kang, Yoon-Koo; Kang, Won K.; Boku, Narikazu; Chung, Hyun C.; Chen, Jen-Shi; Doi, Toshihiko; Sun, Yan; Shen, Lin; Qin, Shukui; Ng, Wai-Tong; Tursi, Jennifer M.; Lechuga, Maria J.; Lu, Dongrui Ray; Ruiz-Garcia, Ana; Sobrero, Alberto Investigational New Drugs, Vol.29 No.6, pp.1449-1458	DOI
2012-04	Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study Kang, Hye Jin; Ryu, Min-Hee; Kim, Kyoung-Mee; Park, Young Soo; Choi, Jene; Ryoo, Baek-Yeol; Kim, Woo Ho; Im, Seock-Ah; Bang, Yung-Jue; Park, Se Hoon; Lee, Jae-Hyuk; Chung, Ik Joo; Bae, Han-Ik; Kim, Jong Gwang; Lee, Kyung Hee; Song, Hong Suk; Kwon, Hyuk-Chan; Baek, Jin Ho; Shin, Dong Bok; Lee, Kyoung Eun; Kang, Yoon-Koo Acta Oncologica, Vol.51 No.4, pp.528-536	DOI
2014-07	Quality of Life in the Trastuzumab for Gastric Cancer Trial Satoh, Taroh; Bang, Yung-Jue; Gotovkin, Evgeny A.; Hamamoto, Yasuo; Kang, Yoon-Koo; Moiseyenko, Vladimir M.; Ohtsu, Atsushi; Van Cutsem, Eric; Al-Sakaff, Nedal; Urspruch, Alexa; Hill, Julie; Weber, Harald A.; Chung, Hyun-Cheol Oncologist, Vol.19 No.7, pp.712-719	DOI
2014-11	A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group Kim, Tae Min; Kim, Dong-Wan; Kang, Yoon-Koo; Chung, Jooseop; Song, Hong-Suk; Kim, Hyo Jung; Kim, Byung Soo; Lee, Jong Seok; Kim, Hawk; Yang, Sung Hyun; Yuh, Young Jin; Bae, Sung Hwa; Hyun, Myung Soo; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Oncologist, Vol.19 No.11, pp.1129-1130	DOI
2016-01	Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial Reichardt, Peter; Demetri, George D.; Gelderblom, Hans; Rutkowski, Piotr; Im, Seock-Ah; Gupta, Sudeep; Kang, Yoon-Koo; Schöffski, Patrick; Schuette, Jochen; Soulières, Denis; Blay, Jean-Yves; Goldstein, David; Fly, Kolette; Huang, Xin; Corsaro, Massimo; Lechuga, Maria Jose; Martini, Jean-Francois; Heinrich, Michael C. BMC Cancer, 16(1):22	view file DOI
2016-08	Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial Pavlakis, Nick; Sjoquist, Katrin M.; Martin, Andrew J.; Tsobanis, Eric; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Alcindor, Thierry; O'Callaghan, Christopher J.; Burnell, Margot J.; Tebbutt, Niall C.; Rha, Sun Young; Lee, Jeeyun; Cho, Jae-Yong; Lipton, Lara R.; Wong, Mark; Strickland, Andrew; Kim, Jin Won; Zalcberg, John R.; Simes, John; Goldstein, David Journal of Clinical Oncology, Vol.34 No.23, pp.2728-2728	DOI
2017-02	The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis Chan, David L.; Sjoquist, Katrin M.; Goldstein, David; Price, Timothy J.; Martin, Andrew J.; Bang, Yung-Jue; Kang, Yoon-Koo; Pavlakis, Nick PLoS ONE, Vol.12 No.2, p. e0172307	DOI
2017-08	A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer Michael, Michael; Bang, Yung-Jue; Park, Young Suk; Kang, Yoon-Koo; Kim, Tae Min; Hamid, Oday; Thornton, Donald; Tate, Sonya C.; Raddad, Eyas; Tie, Jeanne Targeted Oncology, Vol.12 No.4, pp.463-474	DOI
2019-02	Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial Chung, Hyun Cheol; Arkenau, Hendrik-Tobias; Lee, Jeeyun; Rha, Sun Young; Oh, Do-Youn; Wyrwicz, Lucjan; Kang, Yoon-Koo; Lee, Keun-Wook; Infante, Jeffrey R; Lee, Sung Sook; Kemeny, Margaret; Keilholz, Ulrich; Melichar, Bohuslav; Mita, Alain; Plummer, Ruth; Smith, Denis; Gelb, Arnold B; Xiong, Huiling; Hong, Janet; Chand, Vikram; Safran, Howard Journal for ImmunoTherapy of Cancer. 2019 Feb 04;7(1):30	view file DOI
2019-07	Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study Bang, Yung-Jue; Kang, Yoon-Koo; Catenacci, Daniel V.; Muro, Kei; Fuchs, Charles S.; Geva, Ravit; Hara, Hiroki; Golan, Talia; Garrido, Marcelo; Jalal, Shadia I.; Borg, Christophe; Doi, Toshihiko; Yoon, Harry H.; Savage, Mary J.; Wang, Jiangdian; Dalal, Rita P.; Shah, Sukrut; Wainberg, Zev A.; Chung, Hyun Cheol Gastric Cancer, Vol.22 No.4, pp.828-837	DOI
2020-07	Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer Kang, Yoon-Koo; Bang, Yung-Jue; Kondo, Shunsuke; Chung, Hyun Cheol; Muro, Kei; Dussault, Isabelle; Helwig, Christoph; Osada, Motonobu; Doi, Toshihiko Clinical Cancer Research, Vol.26 No.13, pp.3202-3210	DOI
2020-08	Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial Catenacci, Daniel V. T.; Kang, Yoon-Koo; Park, Haeseong; Uronis, Hope E.; Lee, Keun-Wook; Ng, Matthew C. H.; Enzinger, Peter C.; Park, Se Hoon; Gold, Philip J.; Lacy, Jill; Hochster, Howard S.; Oh, Sang Cheul; Kim, Yeul Hong; Marrone, Kristen A.; Kelly, Ronan J.; Juergens, Rosalyn A.; Kim, Jong Gwang; Bendell, Johanna C.; Alcindor, Thierry; Sym, Sun Jin; Song, Eun-Kee; Chee, Cheng Ean; Chao, Yee; Kim, Sunnie; Lockhart, A. Craig; Knutson, Keith L.; Yen, Jennifer; Franovic, Aleksandra; Nordstrom, Jeffrey L.; Li, Daner; Wigginton, Jon; Davidson-Moncada, Jan K.; Rosales, Minori Koshiji; Bang, Yung-Jue The Lancet Oncology, Vol.21 No.8, pp.1066-1076	DOI
2020-08	S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial Kang, Yoon-Koo; Chin, Keisho; Chung, Hyun Cheol; Kadowaki, Shigenori; Oh, Sang Cheul; Nakayama, Norisuke; Lee, Keun-Wook; Hara, Hiroki; Chung, Ik-Joo; Tsuda, Masahiro; Park, Se Hoon; Hosaka, Hisashi; Hironaka, Shuichi; Miyata, Yoshinori; Ryu, Min-Hee; Baba, Hideo; Hyodo, Ichinosuke; Bang, Yung-Jue; Boku, Narikazu The Lancet Oncology, Vol.21 No.8, pp.1045-1056	DOI

Seoul National University Library, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea TEL: 02-880-5567 Email: s-space@snu.ac.kr

RSS 1.0 RSS 2.0 Atom